House Oversight Subcommittee on Health Care Chair McClain Probes FDA Response to Common Over-the-Counter Decongestant Deemed Ineffective
December 05, 2023
December 05, 2023
WASHINGTON, Dec. 5 -- Rep. Lisa McClain, R-Michigan, chairwoman of the House Oversight and Accountability Subcommittee on Health Care and Financial Services, issued the following news release:
Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf requesting a staff-level briefing on the efficacy of over-the-counter drugs after a recent advisory committee concluded a com . . .
Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf requesting a staff-level briefing on the efficacy of over-the-counter drugs after a recent advisory committee concluded a com . . .